Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
29452 ARTÍCULOS , VIENDO DEL 2296 AL 2310
Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease
Zhao X, Hu Q, Wang X, Li C, Chen X, Zhao D, Qiu Y, Xu H, Wang J, Ren L, Zhang N, Li S, Gong P, Hou Y.
Eur J Med Chem. 2024 Dec 5;279:116810. doi: 10.1016/j.ejmech.2024.116810. Epub 2024 Sep 4.
The emerging role of exercise in Alzheimer's disease: Focus on mitochondrial function
Feng L, Li B, Yong SS, Wen X, Tian Z.
Ageing Res Rev. 2024 Nov;101:102486. doi: 10.1016/j.arr.2024.102486. Epub 2024 Sep 6.
The Endocannabinoid System in Alzheimer's Disease: A Network Meta-Analysis
Liu Y, Xing H, Zhang Y, Song Y.
J Neurosci Res. 2024 Sep;102(9):e25380. doi: 10.1002/jnr.25380.
Role of the X Chromosome in Alzheimer Disease Genetics
Belloy ME, Le Guen Y, Stewart I, Williams K, Herz J, Sherva R, Zhang R, Merritt V, Panizzon MS, Hauger RL, Gaziano JM, Logue M, Napolioni V, Greicius MD.
JAMA Neurol. 2024 Oct 1;81(10):1032-1042. doi: 10.1001/jamaneurol.2024.2843.
[Anti-amyloid Antibody Drugs as Disease-Modifying Therapies for Alzheimer's Disease]
Sato K, Iwatsubo T.
Brain Nerve. 2024 Sep;76(9):991-995. doi: 10.11477/mf.1416202723.
[Novel Therapeutic Strategies for Alzheimer's Disease]
Tomita T.
Brain Nerve. 2024 Sep;76(9):1053-1058. doi: 10.11477/mf.1416202732.
Role of Serotonylation and SERT Posttranslational Modifications in Alzheimer's Disease Pathogenesis
Reddy AP, Rawat P, Rohr N, Alvir R, Bisht J, Bushra MA, Luong J, Reddy AP.
Aging Dis. 2024 Mar 28;16(2):841-858. doi: 10.14336/AD.2024.0328.
Unveiling the Intricate Link Between Anaerobe Niche and Alzheimer Disease Pathogenesis
Drakes N, Kondrikova G, Pytel D, Hamlett ED.
J Infect Dis. 2024 Sep 10;230(Supplement_2):S117-S127. doi: 10.1093/infdis/jiae312.
Sensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer's Disease
Bathini P, Brai E, Balin BJ, Bimler L, Corry DB, Devanand DP, Doty RL, Ehrlich GD, Eimer WA, Fulop T, Hahn DL, Hammond CJ, Infanti J, Itzhaki R, Lathe R, Little CS, McLeod R, Moein ST, Nelson AR, Perry G, Shemesh OA, Tanzi RE, Webley WC, Schultek NM, Alberi Auber L.
J Infect Dis. 2024 Sep 10;230(Supplement_2):S150-S164. doi: 10.1093/infdis/jiae328.
Alzheimer's Disease Has Its Origins in Early Life via a Perturbed Microbiome
Ginsberg SD, Blaser MJ.
J Infect Dis. 2024 Sep 10;230(Supplement_2):S141-S149. doi: 10.1093/infdis/jiae200.
Bacterial Membrane Vesicles: The Missing Link Between Bacterial Infection and Alzheimer Disease
Butler CA, Ciccotosto GD, Rygh N, Bijlsma E, Dashper SG, Brown AC.
J Infect Dis. 2024 Sep 10;230(Supplement_2):S87-S94. doi: 10.1093/infdis/jiae228.
Raji CA, Meysami S, Porter VR, Merrill DA, Mendez MF.
BMC Neurol. 2024 Sep 11;24(1):337. doi: 10.1186/s12883-024-03844-4.
Alzheimer's Disease: An Attempt of Total Recall
Bolshakov AP, Gerasimov K, Dobryakova YV.
J Alzheimers Dis. 2024;101(4):1043-1061. doi: 10.3233/JAD-240620.
Amyloid-β-targeting immunotherapies for Alzheimer's disease
Jin Y, Du Q, Song M, Kang R, Zhou J, Zhang H, Ding Y.
J Control Release. 2024 Nov;375:346-365. doi: 10.1016/j.jconrel.2024.09.012. Epub 2024 Sep 18.
Therapeutic Targets in Innate Immunity to Tackle Alzheimer's Disease
Serradas ML, Ding Y, Martorell PV, Kulińska I, Castro-Gomez S.
Cells. 2024 Aug 26;13(17):1426. doi: 10.3390/cells13171426.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.